State-of-the-Art of Flavivirus Virus Research
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against Tropical and other Infectious Diseases".
Deadline for manuscript submissions: 31 July 2025
Special Issue Editor
Interests: virology; vaccinology; microbiology; zoonosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the ecology, diagnosis, and epidemiology of flaviviruses, focusing with a broad focus on recent advances in infection control and vaccine development. Flaviviruses are insect-borne and include Japanese encephalitis, dengue, and tick-borne viruses. They are, therefore, viruses with regional characteristics. Japanese encephalitis, for example, is widely distributed from the Far East to Southeast and South Asia. Worldwide,
30,000-40,000 cases of Japanese encephalitis are reported annually, but the epidemic has already been largely prevented by routine vaccination, including in Japan and South Korea. This Special Issue aims to cover a wide range of the latest findings on flaviviruses involved in their development and research, with the goal of vaccine prevention and infection control.
Prof. Dr. Tomoyoshi Komiya
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- flavivirus
- vaccine
- infection control
- diagnosis
- epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
